Among patients w/ severe AS, ACURATE IDE trial failed to demonstrate that Acurate neo2 valve was noninferior to a commercially available valve. Mortality, stroke & rehospitalization tended to be higher in the Acurate neo2 group vs conventional #TAVR group https://t.co/Yz5QujmvpV #TCT2024
Acceso radial distal para procedimientos coronarios en cualquier escenario clínico: experiencia de los primeros 1.000 pacientes de una cohorte prospectiva #recintervcardiol#AheadOfPrint@NoReflow https://t.co/bIdOZMIc7z
Distal radial access for coronary procedures in an all-comer population: the first 1000 patients in a prospective cohort https://t.co/XecLuWwSj1 #recintervcardiol vía @RevEspCardiol